NMPA Approval

Scopolamine Hydrobromide Injection

Approval Number

国药准字H20033250

Company山东益健药业有限公司

Registration Date

July 15, 2022

Drug Information

Generic Name

氢溴酸东莨菪碱注射液

Dosage Form

注射剂

Strength

1ml:0.3mg

Drug Type

化学药品

Registration Date

July 15, 2022

Company Information

Applicant Company

Company Name山东益健药业有限公司

Company Address

兖州市振华北路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

氢溴酸东莨菪碱注射液 - NMPA 批准文号 | MedPath